Track Omada Health — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Omada Health OMDA · Stock Open Omada Health in new tab

14.33 USD
P/E
37.35
EPS
0.40
P/B
3.39
ROE
5.72
Target Price
26.92 USD
Omada Health logo

Omada Health

🧾 Earnings Recap – Q2 2026

Omada Health’s Q2 earnings drove a +23.9% stock rally, fueled by notable revenue growth, margin expansion, and strong membership gains that clearly outpaced expectations.

  • Revenue grew 43% year-over-year, marking a record quarter for the company.
  • Gross margin expanded significantly by 700 basis points on a GAAP basis to 73%, and by 600 basis points on a non-GAAP basis to 74%.
  • Membership surged 45% year-over-year to 1.1 million active members, demonstrating strong program adoption.
  • The company turned profitable with $5 million in net income and $11 million in adjusted EBITDA, reversing losses from the prior year.
  • Commercial momentum continued with new customer wins across diverse sectors and expansion with a major health plan adding 1.5 million covered lives starting in 2027.
📅
Loading chart...
Key Metrics
Earnings dateMarch 4, 2027
P/E37.35
EPS0.40
Book Value4.41
Price to Book3.39
Debt/Equity13.99
% Insiders2.116%
Growth
Revenue Growth0.34%
Estimates
Forward P/E22.49
Forward EPS0.66
Target Mean Price26.92

DCF valuation

Model fair value for Omada Health (OMDA)
Result
Sign in to run the valuation for OMDA.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
12 analysts · consensus Buy · mean target 26.92 USD (low 19.00, high 35.00) · as of 12 Nov 2026
Low 19.00
Mean 26.92
High 35.00
Price 14.33
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Omada Health Logo Omada Health Analysis (OMDA)

Is Omada Health a good investment? Omada Health (OMDA) is currently trading at 14.33 USD. Market analysts have a consensus price target of 26.92 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 37.35. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Omada Health is expected to release its next earnings report on March 4, 2027. The market consensus estimate for Forward EPS is 0.66.

Investor FAQ

Does Omada Health pay a dividend?

No, it does not currently pay a dividend.

What asset class is Omada Health?

Omada Health is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 4, 2027. The company currently has a trailing EPS of 0.40.

Company Profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Exchange Ticker
OMDA
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion